amlodipine and valsartan (Exforge)
Title: amlodipine and valsartan (Exforge)Category: MedicationsCreated: 7/27/2010 12:00:00 AMLast Editorial Review: 3/19/2019 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - March 19, 2019 Category: Cardiology Source Type: news
Cheap blood pressure drugs could increase survival chances for men with prostate cancer
Scientists at the Universtiy of Tampere in Finland led the study. They found the class of blood pressure drug called angiotensin II receptor blockers had the benefit. They include pills such as valsartan. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2019 Category: Consumer Health News Source Type: news
Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy
At the Annual Meeting of the Global Chagas Disease Coalition in Barcelona, Spain, Novartis announced that it is joining the Coalition as a member contributor. In addition, the company announced its commitment to launch a multinational, prospective, randomized study with heart failure drug, Entresto® (sacubitril / valsartan), in people with chronic Chagas cardiomyopathy, one form of heart failure with reduced ejection fraction. (Source: World Pharma News)
Source: World Pharma News - March 15, 2019 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
FDA combats valsartan shortage with new generic approval
As recalls widen for the popular blood pressure medication, valsartan, the FDA has approved a new generic version of the drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - March 14, 2019 Category: Pharmaceuticals Source Type: news
FDA Approves New Generic Valsartan to Ease Shortage
WEDNESDAY, March 13, 2019 -- The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication shortage.
The agency said it... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 13, 2019 Category: Pharmaceuticals Source Type: news
After multiple recalls, FDA OK's new generic for valsartan
FDA said new approval will help alleviate shortages of blood pressure drugs after repeated recalls over cancer-causing chemicals (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 13, 2019 Category: Consumer Health News Source Type: news
FDA OKs a New Generic of the Blood Pressure Drug Valsartan to Ease Shortage Due to Recalls
WEDNESDAY, March 13, 2019 -- The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication shortage.
The agency said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 13, 2019 Category: General Medicine Source Type: news
FDA Fast-Tracks Approval of Generic Valsartan FDA Fast-Tracks Approval of Generic Valsartan
Amid ongoing tainted sartan drug recalls, the US Food and Drug Administration has approved a new generic of valsartan (Diovan) to treat hypertension and heart failure.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 12, 2019 Category: Neurology Tags: Cardiology News Alert Source Type: news
FDA Allows For a New Generic Valsartan
(MedPage Today) -- Approval comes in response to ARB shortage (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - March 12, 2019 Category: Pediatrics Source Type: news
FDA Allows New Generic Valsartan
(MedPage Today) -- Approval comes in response to ARB shortage (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - March 12, 2019 Category: Pediatrics Source Type: news
FDA approves a new generic valsartan
Today, the U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine (Source: World Pharma News)
Source: World Pharma News - March 12, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
FDA approves new generic valsartan to make up for drug shortage
The US Food and Drug Administration approved a new generic of valsartan on Tuesday to help relieve the recent shortage of the medicine, which is used to treat high blood pressure. (Source: CNN.com - Health)
Source: CNN.com - Health - March 12, 2019 Category: Consumer Health News Source Type: news
FDA approves generic valsartan amid drug shortage
The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages triggered by several manufacturers recalling the drug over possible cancer risk. (Source: Reuters: Health)
Source: Reuters: Health - March 12, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
FDA Approves a New Generic Diovan (valsartan)
March 12, 2019 -- Today, the U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA prioritized the review of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 12, 2019 Category: Pharmaceuticals Source Type: news
FDA approves a new generic valsartan
FDA has approved a new generic of Diovan (valsartan). The agency prioritized the review of this drug application to help relieve a recent shortage of the drug. (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 12, 2019 Category: American Health Source Type: news
